Tony Reid

Tony Reid

Company: EpicentRx

Job title: President & CEO

Seminars:

Fireside Chat: Assessing the TGF-β Landscape & Predicting Future Innovations 9:30 am

Exploring the current clinical successes of TGF-β targeted therapies Discussing the changes in the TGF-β field with the pivot to fibrosis research Looking to the future for developing TGF-β directed therapies and exciting new technologies using TGF-βRead more

day: Conference Day One

The Accomplishments of TGF-β Directed Therapies in Immuno-Oncology 9:00 am

Navigating from preclinical to clinical trials in immuno-oncology to maintain positive patient response Unearthing clinical efficacy and activity of TGF-β targeted therapy to celebrate success Discovering the next steps in the TGF-β space for clinical triumph New Data!Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.